Want to see HK:8437 full AI Analyst Report?
Top Page
RMH Holdings Limited
(8437)
Select Model
Select Model
Rating:41Neutral
Price Target:
HK$0.24
▼(-27.58% Downside)
Action:Reiterated
Date:01/21/26
The score is driven primarily by very weak financial performance (declining revenue, persistent losses, negative equity, and weak cash generation). Technical indicators are also unfavorable (price below key short-term averages, negative MACD, very low RSI). Valuation is constrained by negative earnings and no dividend data.
Positive Factors
Diversified Business Mix
A multi‑sector investment model spreads revenue sources across real estate rents, management fees and tech dividends. That structural diversification can smooth cash flow cycles, enable capital allocation across opportunities, and reduce single‑sector exposure over months.
Negative Factors
Negative Shareholders' Equity
Negative equity is a structural solvency red flag that limits access to conventional capital, increases refinancing and covenant risk, and may force asset sales or recapitalization. This weakens long‑term financial flexibility and heightens execution risk over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Business Mix
A multi‑sector investment model spreads revenue sources across real estate rents, management fees and tech dividends. That structural diversification can smooth cash flow cycles, enable capital allocation across opportunities, and reduce single‑sector exposure over months.
Read all positive factors
RMH Holdings Limited (8437) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$16.65M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)1.13
Revenue GrowthN/A
EPS GrowthN/A
CountryHK
Employees45
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.07
Shares Outstanding66,600,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.15
Price to Sales (P/S)0.59
P/FCF Ratio26.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RMH Holdings Limited Business Overview & Revenue Model
Company Description
RMH Holdings Limited, an investment holding company headquartered in Singapore and incorporated in 2017, delivers a diverse range of medical, dermatological, and aesthetic products and services across Singapore, Hong Kong, and international market...
RMH Holdings Limited Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
20
Very Negative
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.22M | 5.04M | 3.18M | 4.24M | 238.00K | 7.81M |
| Gross Profit | -1.01M | 3.15M | 1.54M | 707.00K | -2.05M | 5.12M |
| EBITDA | -3.85M | -2.60M | -5.00M | -7.84M | -2.59M | -6.47M |
| Net Income | -5.06M | -3.51M | -6.75M | -18.65M | -8.79M | -9.27M |
Balance Sheet | ||||||
| Total Assets | 4.92M | 3.97M | 4.15M | 12.40M | 18.91M | 20.49M |
| Cash, Cash Equivalents and Short-Term Investments | 557.00K | 566.00K | 306.00K | 2.12M | 2.75M | 4.93M |
| Total Debt | 4.10M | 4.28M | 258.00K | 5.35M | 11.06M | 11.76M |
| Total Liabilities | 29.12M | 28.38M | 16.67M | 18.69M | 14.34M | 14.96M |
| Stockholders Equity | -19.27M | -19.50M | -12.41M | -6.29M | 4.57M | 5.53M |
Cash Flow | ||||||
| Free Cash Flow | -8.51M | 113.00K | 368.00K | -6.41M | -7.33M | -6.64M |
| Operating Cash Flow | -8.50M | 114.00K | 781.00K | -5.09M | -6.13M | -4.51M |
| Investing Cash Flow | 6.61M | 142.00K | 1.52M | -3.28M | -506.00K | -6.69M |
| Financing Cash Flow | 1.06M | -4.00K | -2.46M | 6.65M | 3.82M | 3.47M |
RMH Holdings Limited Technical Analysis
Negative
0.33
Price Trends
0.25
Negative
0.25
Positive
0.28
Negative
Market Momentum
>-0.01
Negative
34.65
Neutral
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8437, the sentiment is Negative. The current price of 0.33 is above the 20-day moving average (MA) of 0.25, above the 50-day MA of 0.25, and above the 200-day MA of 0.28, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 34.65 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8437.
RMH Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$4.53B | 11.13 | 33.37% | 4.04% | 16.70% | 38.98% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | HK$19.55M | -6.03 | -32.49% | ― | -21.61% | -140.20% | |
41 Neutral | HK$16.65M | -7.19 | 1.96% | ― | ― | ― | |
40 Underperform | HK$63.51M | 4.33 | 12.17% | ― | 36.68% | ― | |
33 Underperform | HK$48.01M | 1,210.00 | 0.90% | 7.69% | 6.13% | ― |
* Healthcare Sector Average
HK:8437
RMH Holdings Limited
0.25
0.09
56.25%
HK:1947
Meihao Medical Group Co., Ltd.
0.56
0.23
68.18%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.12
<0.01
0.83%
HK:2373
Beauty Farm Medical & Health Industry, Inc.
17.82
-15.35
-46.28%
HK:8161
MediNet Group Ltd.
0.47
-0.16
-25.40%
HK:8307
Medicskin Holdings Ltd.
0.12
-0.10
-45.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.